secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2026-05-06T23:59:59+00:00
Accession:  0001472375-26-000133
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Regenerex Pharma terminates CFO Kenneth Perry for cause; appoints Don E. Ray as interim CFO
--------------------------------------------------------------------------------

- Kenneth Perry placed on administrative suspension with pay on March 31, 2026.
- Board determined Perry's conduct constituted material breach and 'Cause' under employment agreement; termination effective May 2, 2026.
- Don E. Ray appointed Interim CFO effective April 1, 2026 for an initial 90-day term.
- CEO Greg Pilant recused himself from deliberations; independent board made decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237526000133/0001472375-26-000133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237526000133/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-26-000133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer